2020-2025 Global Recombinant Factor VIII Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

Factor VIII is a medication used to treat and prevent bleeding in people with hemophilia A and other causes of low factor VIII. Certain preparations may also be used in those with von Willebrand's disease.It is given by slow injection into a vein.
This report elaborates the market size, market characteristics, and market growth of the Recombinant Factor VIII industry, and breaks down according to the type, application, and consumption area of Recombinant Factor VIII. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Recombinant Factor VIII in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Recombinant Factor VIII market covered in Chapter 13:
Octapharma
Grifols
ProSpec
BPL
NovoNordisk
RAAS
Biogen
Kedrion
Hualan Bio
Pfizer
Greencross
CSL Behring
Shire
Bayer

In Chapter 6, on the basis of types, the Recombinant Factor VIII market from 2015 to 2025 is primarily split into:
Recombinant Factor VIII
Plasma-derived Factor VIII

In Chapter 7, on the basis of applications, the Recombinant Factor VIII market from 2015 to 2025 covers:
Hemophilia A
Spontanous / Trauma
Surgical
Others

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:

Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025